These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10225565)

  • 21. Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay.
    Olive PL; Horsman MR; Grau C; Overgaard J
    Br J Cancer; 1997; 76(6):694-9. PubMed ID: 9310232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
    Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
    Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent.
    Kyle AH; Huxham LA; Baker JH; Burston HE; Minchinton AI
    Cancer Res; 2003 Sep; 63(18):5707-11. PubMed ID: 14522888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell kinetics in mouse epidermis studied by bivariate DNA/bromodeoxyuridine and DNA/keratin flow cytometry.
    Kirkhus B; Clausen OP
    Cytometry; 1990; 11(2):253-60. PubMed ID: 1690627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay.
    McLaren DB; Pickles T; Thomson T; Olive PL
    Radiother Oncol; 1997 Nov; 45(2):175-82. PubMed ID: 9424009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours.
    Eriksson D; Joniani HM; Sheikholvaezin A; Löfroth PO; Johansson L; Riklund Ahlström K; Stigbrand T
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):895-906. PubMed ID: 12721768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
    Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
    Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The occurrence of apoptosis, abnormal mitoses, cells dying in mitosis and micronuclei in a human melanoma xenograft exposed to single dose irradiation.
    Falkvoll KH
    Strahlenther Onkol; 1990 Jul; 166(7):487-92. PubMed ID: 2382212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of single dose irradiation on the proliferation kinetics in a human malignant melanoma in athymic nude mice.
    Rofstad EK; Lindmo T; Brustad T
    Acta Radiol Oncol; 1980; 19(4):261-9. PubMed ID: 6257048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ratio of initial/residual DNA damage predicts intrinsic radiosensitivity in seven cervix carcinoma cell lines.
    Marples B; Longhurst D; Eastham AM; West CM
    Br J Cancer; 1998 Apr; 77(7):1108-14. PubMed ID: 9569047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44+/CD24+ cervical cancer cells resist radiotherapy and exhibit properties of cancer stem cells.
    Liu H; Wang YJ; Bian L; Fang ZH; Zhang QY; Cheng JX
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1745-54. PubMed ID: 27212166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
    Tsang RW; Wong CS; Fyles AW; Levin W; Manchul LA; Milosevic M; Chapman W; Li YQ; Pintilie M
    Radiother Oncol; 1999 Jan; 50(1):93-101. PubMed ID: 10225562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.
    Bolger BS; Cooke TG; Symonds RP; MacLean AB; Stanton PD
    Br J Cancer; 1993 Jul; 68(1):166-71. PubMed ID: 8318408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of irradiation on bromodeoxyuridine incorporation in human colon cancer xenografts.
    Lawrence TS; Chang EY; Davis MA; Stetson PL; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):617-21. PubMed ID: 8621286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice.
    Petersen C; Eicheler W; Frömmel A; Krause M; Balschukat S; Zips D; Baumann M
    Int J Radiat Biol; 2003 Jul; 79(7):469-77. PubMed ID: 14530154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
    Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
    Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NO38 expression and nucleolar counts are correlated with cellular DNA content but not with proliferation parameters in colorectal carcinomas.
    De Angelis PM; Stokke T; Clausen OP
    Mol Pathol; 1997 Aug; 50(4):201-8. PubMed ID: 9350304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. gammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation.
    Bañuelos CA; Banáth JP; Kim JY; Aquino-Parsons C; Olive PL
    Clin Cancer Res; 2009 May; 15(10):3344-53. PubMed ID: 19401347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA damage following combination of radiation with the bioreductive drug AQ4N: possible selective toxicity to oxic and hypoxic tumour cells.
    Hejmadi MV; McKeown SR; Friery OP; McIntyre IA; Patterson LH; Hirst DG
    Br J Cancer; 1996 Feb; 73(4):499-505. PubMed ID: 8595165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.